Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit - Quiz - MDSpire

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit

  • By

  • Anoop T. M.

  • Rona Joseph

  • Sherin Mathew

  • Mintu Mathew

  • Saikumar Soman

  • Kalai Bharathi

  • Senthamizhan S

  • May 18, 2026

  • 0 min

Share

Original Source(s)

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit

  • by Anoop T. M., Rona Joseph, Sherin Mathew, Mintu Mathew, Saikumar Soman, Kalai Bharathi, Senthamizhan S

  • May 18, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2